Status:
COMPLETED
The Effect of NMES on Bowel Management in People with Chronic SCI
Lead Sponsor:
Swiss Paraplegic Research, Nottwil
Conditions:
Electric Stimulation Therapy
Bowel Dysfunction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It has been reported that 62% of all people with Spinal Cord Injury (SCI) have experienced faecal incontinence and that neurogenic bowel dysfunction (NBD) is a major sequela. As an alternative to abdo...
Detailed Description
A SCI entails devastating changes to a person's life. The extent of these changes depends on the level and degree of the lesion. NBD is one of the most important sequelae occurring in the majority of ...
Eligibility Criteria
Inclusion
- Traumatic and non-traumatic SCI; \> 1 year
- Level of lesion: C2 - L5
- AIS score A/B/C/D
- Age: ≥ 18 years
- Urge to reduce defaecation time
Exclusion
- Patients during primary rehabilitation
- Bladder stimulator
- Autonomic dysreflexia by application of ES of the abdominal wall
- Pregnancy: test in women of childbearing age (15 - 49 years)
- Opioid use
- Inflammatory bowel disease
- Cancerous tissue in abdominal region
- Patients' inability to follow the study, e.g. mental-health problems, language problems, dementia etc.
Key Trial Info
Start Date :
July 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04914975
Start Date
July 4 2021
End Date
October 30 2024
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Swiss Paraplegic Centre
Nottwil, Canton of Lucerne, Switzerland, 6207